10-Q: USANA Health Sciences Reports Q2 Loss Amidst Goodwill Impairment

USANA Health Sciences reported a net loss of $21.4 million for the second quarter of 2026, impacted by a $29.1 million goodwill impairment charge for its Hiya segment and declining sales in its Core Nutritional business.

Summary

• USANA Health Sciences reported a net loss of $21.4 million for the second quarter ended July 4, 2026, a significant decrease from a net earning of $9.7 million in the prior year's quarter.
• The company recorded a non-cash goodwill impairment charge of $29.1 million related to its Hiya reporting unit.
• Consolidated net sales decreased by 5.3% to $223.3 million, primarily driven by declines in the Core Nutritional and Hiya segments.
• The Core Nutritional segment saw a 4.0% decrease in net sales to $191.6 million, with a 6.8% decline on a constant currency basis, attributed to a decrease in active customers.
• Hiya segment net sales decreased by 16.7% to $28.3 million due to a challenging digital marketing environment.
• Rise segment net sales increased by 40.3% to $3.4 million, driven by the sales of Protein Pop.
• Diluted loss per share was $(1.16) compared to diluted earnings per share of $0.52 in the prior year.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative sentiment due to a significant net loss, a substantial goodwill impairment, and declining sales in key segments, despite some positive operational adjustments.

Positives

• Rise segment net sales increased significantly by 40.3% to $3.4 million, driven by new product sales.
• Hiya's gross margins improved by 410 basis points to 67.9% due to savings in shipping costs and favorable sales mix.
• The company's liquidity remains adequate, with cash and cash equivalents increasing to $168.6 million.
• Cost realignment initiatives in the Core Nutritional business led to a decrease in selling, general, and administrative expenses relative to net sales.

Negatives

• Reported a net loss of $21.4 million for the quarter, compared to a net earning of $9.7 million in the prior year.
• Recorded a substantial non-cash goodwill impairment charge of $29.1 million for the Hiya segment.
• Consolidated net sales decreased by 5.3% to $223.3 million.
• Core Nutritional segment net sales declined 4.0% (6.8% constant currency) due to a decrease in active customers.
• Hiya segment net sales decreased by 16.7% due to a challenging digital marketing environment.
• Active customers in the Core Nutritional business decreased by 8.1% year-over-year.
• Diluted loss per share was $(1.16), a significant drop from $0.52 earnings per share in the prior year.

Risks

• Dependence on the Core Nutritional business model and Brand Partners, which has experienced declining sales, net income, and active customers.
• Challenges in attracting new customers in both the Core Nutritional and Hiya segments.
• The evolution to an omni-channel health and wellness company relies on the performance of acquired direct-to-consumer businesses like Hiya and Rise.
• Extensive regulation of the Core Nutritional business and uncertainties in China.
• Macroeconomic conditions, including inflationary pressures and slower economic growth, could impact consumer spending.
• Hiya's growth strategy is dependent on adapting to changes in the digital marketing environment.
• Rise's revenue is dependent on ordering patterns from key retailers, with no long-term supply agreements.
• Geopolitical tensions and trade policies could impact international operations and competition.

Future Outlook

The company believes its current cash balances, future cash provided by operations, and available line of credit are sufficient for foreseeable operating and capital needs. However, it acknowledges that additional financing may be required for adverse operating environments, unanticipated capital expenditures, market expansion, or acquisitions, which could result in dilution to shareholders.

Management Comments

• The Company remains confident in the future of Hiya and recognizes the strategic importance as part of our consolidated long-term growth strategy as Hiya leverages their brand across additional channels and international markets.
• We believe our current liquidity, through cash flow from operations along with our line of credit, is adequate to meet our cash requirements and sustain our operations.
• Maintaining a capital structure that emphasizes sufficient liquidity and adaptability in the prevailing economic climate is our top priority.

Industry Context

StockSavvy.ai notes that USANA's performance reflects broader challenges in the direct selling and health supplement industry, including increased competition, evolving consumer preferences towards omni-channel purchasing, and difficulties in customer acquisition, particularly in digital marketing environments.

Comparison to Industry Standards

• The decline in active customers for USANA's Core Nutritional business (8.1% year-over-year) is a concern, as many direct selling companies focus on customer base growth as a primary metric.
• The significant goodwill impairment for Hiya suggests that the integration and expected synergies from the acquisition may not be materializing as planned, which is a risk seen across various industries when acquiring direct-to-consumer businesses.
• The shift towards omni-channel strategies, including direct-to-consumer and retail, is a common trend, but USANA's execution, particularly with Hiya's digital marketing challenges and Rise's reliance on retailer orders, indicates a difficult competitive landscape.
• Competitors like Herbalife Nutrition and Nu Skin Enterprises also face challenges in customer acquisition and regulatory scrutiny, but their scale and diversified market presence may offer more resilience.

Legal Proceedings

• The Company is involved in various lawsuits, claims, and other legal matters arising in the ordinary course of business, including those related to products, intellectual property, supplier relationships, distributors, competitors, and employees. Management does not currently believe these matters, individually or in aggregate, will have a material adverse effect on financial condition, liquidity, or results of operations.

Stakeholder Impact

• Shareholders: Negative impact due to net loss, diluted loss per share, and goodwill impairment, potentially affecting stock price.
• Brand Partners: Potential impact from declining customer base and challenging sales environment in the Core Nutritional segment.
• Customers: Continued access to products, but potential impact from company's strategic shifts and market challenges.
• Creditors: Company's liquidity and credit facility terms suggest no immediate concern, but sustained losses could impact future creditworthiness.

Next Steps

• Continue to invest in R&D and product innovation.
• Focus on increasing the cadence of new product releases.
• Expand Hiya's distribution into additional channels and international markets.
• Continue to build Rise's retail opportunity.
• Monitor and adapt to changes in the digital marketing environment.
• Manage supply chain and raw material costs.
• Comply with evolving legal and regulatory environments globally.

Key Dates

Recommendation

The significant net loss, substantial goodwill impairment, declining sales in core segments, and a decrease in active customers indicate worsening financial performance and operational challenges. While the company maintains adequate liquidity, the negative trends and future uncertainties outweigh the positives, suggesting a sell recommendation.

Keywords

USANA Health Sciences, Nutritional Supplements, Direct Selling, Health and Wellness, Goodwill Impairment, Quarterly Report, Hiya, Rise